Paramyxovirus: Difference between revisions
Brian Blank (talk | contribs) No edit summary |
No edit summary |
||
| Line 17: | Line 17: | ||
}} | }} | ||
{{SI}} | {{SI}} | ||
{{ | {{CMG}} | ||
==Overview== | ==Overview== | ||
| Line 78: | Line 78: | ||
Hendra virus (HeV) and Nipah virus (NiV) in the genus [[Henipavirus]] have emerged in humans and livestock in Australia and Southeast Asia. Both viruses are [[contagious]], highly [[virulent]], and capable of infecting a number of mammalian species and causing potentially fatal disease. Due to the lack of a licensed [[vaccine]] or antiviral therapies, HeV and NiV are designated as biosafety level (BSL) 4 agents. The genomic structure of both viruses is that of a typical paramyxovirus.<ref name=sobrino5>{{cite book |chapterurl=http://www.horizonpress.com/avir|author=Sawatsky et al|year=2008|chapter=Hendra and Nipah Virus|title=Animal Viruses: Molecular Biology|publisher=Caister Academic Press|id=[http://www.horizonpress.com/avir ISBN 978-1-904455-22-6]}}</ref> | Hendra virus (HeV) and Nipah virus (NiV) in the genus [[Henipavirus]] have emerged in humans and livestock in Australia and Southeast Asia. Both viruses are [[contagious]], highly [[virulent]], and capable of infecting a number of mammalian species and causing potentially fatal disease. Due to the lack of a licensed [[vaccine]] or antiviral therapies, HeV and NiV are designated as biosafety level (BSL) 4 agents. The genomic structure of both viruses is that of a typical paramyxovirus.<ref name=sobrino5>{{cite book |chapterurl=http://www.horizonpress.com/avir|author=Sawatsky et al|year=2008|chapter=Hendra and Nipah Virus|title=Animal Viruses: Molecular Biology|publisher=Caister Academic Press|id=[http://www.horizonpress.com/avir ISBN 978-1-904455-22-6]}}</ref> | ||
== | ==Related chapters== | ||
*[[Animal virology|Animal viruses]] | *[[Animal virology|Animal viruses]] | ||
*[[Virology]] | *[[Virology]] | ||
*[[Henipavirus]] | *[[Henipavirus]] | ||
== | ==Resources== | ||
*[http://www.tulane.edu/~dmsander/WWW/335/Paramyxoviruses.html Paramyxoviruses (1998)] — morphology, genome, replication, pathogenesis | *[http://www.tulane.edu/~dmsander/WWW/335/Paramyxoviruses.html Paramyxoviruses (1998)] — morphology, genome, replication, pathogenesis | ||
*[http://datamining.csiro.au/files/mediaRelease/mr2001/Paramyxovirus.htm ''Hendra virus has a growing family tree'' (2001)] CSIRO Paramyxovirus press release | *[http://datamining.csiro.au/files/mediaRelease/mr2001/Paramyxovirus.htm ''Hendra virus has a growing family tree'' (2001)] CSIRO Paramyxovirus press release | ||
*[http://www.horizonpress.com/gateway/animal-viruses.html Animal viruses] | *[http://www.horizonpress.com/gateway/animal-viruses.html Animal viruses] | ||
==References== | |||
{{reflist|2}} | |||
== References == | |||
{{reflist}} | |||
[[es:Paramyxoviridae]] | [[es:Paramyxoviridae]] | ||
| Line 102: | Line 99: | ||
{{SIB}} | {{SIB}} | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
| Line 108: | Line 108: | ||
[[pl:Paramyksowirusy]] | [[pl:Paramyksowirusy]] | ||
Revision as of 19:56, 8 March 2012
| style="background:#Template:Taxobox colour;"|Paramyxovirus | ||||||
|---|---|---|---|---|---|---|
| style="background:#Template:Taxobox colour;" | Virus classification | ||||||
| ||||||
| Genera | ||||||
|
Subfamily Paramyxovirinae |
|
WikiDoc Resources for Paramyxovirus |
|
Articles |
|---|
|
Most recent articles on Paramyxovirus Most cited articles on Paramyxovirus |
|
Media |
|
Powerpoint slides on Paramyxovirus |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Paramyxovirus at Clinical Trials.gov Trial results on Paramyxovirus Clinical Trials on Paramyxovirus at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Paramyxovirus NICE Guidance on Paramyxovirus
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Paramyxovirus Discussion groups on Paramyxovirus Patient Handouts on Paramyxovirus Directions to Hospitals Treating Paramyxovirus Risk calculators and risk factors for Paramyxovirus
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Paramyxovirus |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Paramyxoviruses are viruses of the Paramyxoviridae family of the Mononegavirales order; they are negative-sense single-stranded RNA viruses responsible for a number of human and animal diseases.
Genera
- Subfamily Paramyxovirinae
- Genus Avulavirus (type species Newcastle disease virus)
- Genus Henipavirus (type species Hendravirus; others include Nipahvirus)
- Genus Morbillivirus (type species Measles virus; others include Rinderpest virus, Canine distemper virus, phocine distemper virus)
- Genus Respirovirus (type species Sendai virus; others include Human parainfluenza viruses 1 and 3, as well some of the viruses of the common cold)
- Genus Rubulavirus (type species Mumps virus; others include Simian parainfluenza virus 5, Menangle virus, Tioman virus)
- Genus TPMV-like viruses (type species Tupaia paramyxovirus)
- Subfamily Pneumovirinae
- Genus Pneumovirus (type species Human respiratory syncytial virus, others include Bovine respiratory syncytial virus)
- Genus Metapneumovirus (type species Avian pneumovirus, Human metapneumovirus)
- Unassigned viruses
- Fer-de-Lance virus
- Nariva virus
- Tupaia paramyxovirus
- Salem virus
- J virus
- Mossman virus
- Beilong virus
Physical structure
Virions are enveloped and can be spherical, filamentous or pleomorphic. Fusion proteins and attachment proteins appear as spikes on the virion surface. Matrix proteins inside the envelope stabilise virus structure. The nucleocapsid core is composed of the genomic RNA, nucleocapsid proteins, phosphoproteins and polymerase proteins.
Genome structure
The genome consists of a single segment of negative-sense RNA, 15-19 kilobases in length and containing 6-10 genes. Extracistronic (non-coding) regions include:
- A 3’ leader sequence, 50 nucleotides in length which acts as a transcriptional promoter.
- A 5’ trailer sequence, 50-161 nucleotides long
- Intergenomic regions between each gene which are three nucleotides long for morbillivirus, respirovirus and henipavirus, variable length (1-56 nucleotides) for rubulavirus and pneumovirinae.
Each gene contains transcription start/stop signals at the beginning and end which are transcribed as part of the gene.
Gene sequence within the genome is conserved across the family due to a phenomenon known as transcriptional polarity (see Mononegavirales) in which genes closest to the 3’ end of the genome are transcribed in greater abundance than those towards the 5’ end. This mechanism acts as a form of transcriptional regulation.
The gene sequence is:
- Nucleocapsid – Phosphoprotein – Matrix – Fusion – Attachment – Large (polymerase)
Proteins
- N – the nucleocapsid protein associates with genomic RNA (one molecule per hexamer) and protects the RNA from nuclease digestion
- P – the phosphoprotein binds to the N and L proteins and forms part of the RNA polymerase complex
- M – the matrix protein assembles between the envelope and the nucleocapsid core, it organizes and maintains virion structure
- F – the fusion protein projects from the envelope surface as a trimer, and mediates cell entry by inducing fusion between the viral envelope and the cell membrane by class I fusion. One of the defining characteristics of members of the paramyxoviridae family is the requirement for a neutral pH for fusogenic activity.
- H/HN/G – the cell attachment proteins span the viral envelope and project from the surface as spikes. They bind to sialic acid on the cell surface and facilitate cell entry. Note that the receptor for measles virus is unknown. Proteins are designated H for morbilliviruses and henipaviruses as they possess haemagglutination activity, observed as an ability to cause red blood cells to clump. HN attachment proteins occur in respiroviruses and rubulaviruses. These possess both haemagglutination and neuraminidase activity which cleaves sialic acid on the cell surface, preventing viral particles from reattaching to previously infected cells. Attachment proteins with neither haemagglutination nor neuraminidase activity are designated G (glycoprotein). These occur in members of pneumovirinae.
- L – the large protein is the catalytic subunit of RNA dependent RNA polymerase (RDRP)
- Accessory proteins – a mechanism known as RNA editing (see Mononegavirales) allows multiple proteins to be produced from the P gene. These are not essential for replication but may aid in survival in vitro or may be involved in regulating the switch from mRNA synthesis to antigenome synthesis.
Pathogenic paramyxoviruses
A number of important human diseases are caused by paramyxoviruses. These include mumps, measles, which caused 745,000 deaths in 2001 and respiratory syncytial virus (RSV) which is the major cause of bronchiolitis and pneumonia in infants and children.
The parainfluenza viruses are the second most common causes of respiratory tract disease in infants and children. They can cause pneumonia, bronchitis and croup in children and the elderly.
Human metapneumovirus, initially described in about 2001, is also implicated in bronchitis, especially in children.
Paramyxoviruses are also responsible for a range of diseases in other animal species, for example canine distemper virus (dogs), phocine distemper virus (seals), cetacean morbillivirus (dolphins and porpoises) Newcastle disease virus (birds) and rinderpest virus (cattle). Some paramyxoviruses such as the henipaviruses are zoonotic pathogens, occurring naturally in an animal host, but also able to infect humans.
Hendra virus (HeV) and Nipah virus (NiV) in the genus Henipavirus have emerged in humans and livestock in Australia and Southeast Asia. Both viruses are contagious, highly virulent, and capable of infecting a number of mammalian species and causing potentially fatal disease. Due to the lack of a licensed vaccine or antiviral therapies, HeV and NiV are designated as biosafety level (BSL) 4 agents. The genomic structure of both viruses is that of a typical paramyxovirus.[1]
Related chapters
Resources
- Paramyxoviruses (1998) — morphology, genome, replication, pathogenesis
- Hendra virus has a growing family tree (2001) CSIRO Paramyxovirus press release
- Animal viruses
References
- ↑ Sawatsky; et al. (2008). "Hendra and Nipah Virus". Animal Viruses: Molecular Biology. Caister Academic Press. ISBN 978-1-904455-22-6.